SGMT

Sagimet Biosciences Inc.$8.47+0.35 (+4.31%)

Prev Close$8.12·MCap$166.8M·P/E—·Vol2.94M·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$1.17M

◆

Net Activity

Net Seller

$1.17M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Sagimet Biosciences Inc. (SGMT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $1.17M. The most recent insider transaction was by Chauche Thierry (officer: Chief Financial Officer), who sold $7.0K worth of shares on Feb 12, 2026. Sagimet Biosciences Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $166.8M.

SGMT Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 12, 2026	Chauche Thierry	officer: Chief Financial Officer	Sell	1,312	$5.36	$7.0K	15,688
Feb 12, 2026	Happel David	director, officer: President & CEO	Sell	12,101	$5.36	$64.9K	677,621
Feb 12, 2026	Martins Eduardo Bruno	officer: Chief Medical Officer	Sell	3,640	$5.36	$19.5K	103,296
Feb 12, 2026	Rozek Elizabeth	officer: Chief Legal & Admin. Officer	Sell	2,622	$5.36	$14.1K	190,959
Nov 21, 2025	Kemble George	Executive Chairman	Sell	37,688	$7.69	$290.0K	81,005-32%
Jul 23, 2025	Happel David	President & CEO	Sell	65,478	$9.13	$598.1K	689,722
Jul 23, 2025	Martins Eduardo Bruno	Chief Medical Officer	Sell	8,277	$9.13	$75.6K	106,936
Jul 23, 2025	Rozek Elizabeth	General Counsel and CCO	Sell	10,780	$9.13	$98.5K	183,726
Jul 25, 2024	Kemble George	Executive Chairman	Sell	23,625	$3.17	$74.8K	118,693
Jul 23, 2024	Kemble George	Executive Chairman	Sell	14,062	$3.10	$43.6K	142,318
Jul 23, 2024	Martins Eduardo Bruno	Chief Medical Officer	Sell	8,357	$3.10	$25.9K	81,213
Jul 23, 2024	Rozek Elizabeth	General Counsel and CCO	Sell	10,914	$3.10	$33.8K	160,506
Mar 28, 2024	Happel David	President & CEO	Buy	12,100	$5.27	$63.7K	639,200
Dec 8, 2023	Happel David	President & CEO	Buy	1,600	$4.10	$6.6K	627,100
Nov 20, 2023	Happel David	President & CEO	Buy	590	$2.35	$1.4K	590
Jul 20, 2023	NEW ENTERPRISE ASSOCIATES 13 LP	10% Owner	Buy	30,000	$16.00	$480.0K	3,850,275
Jul 20, 2023	NEW ENTERPRISE ASSOCIATES 13 LP	10% Owner	Sell	662	$16.00	$10.6K	3,820,275
Jul 20, 2023	SEIDENBERG BETH C	Director	Buy	46,875	$16.00	$750.0K	46,875

SGMT Insider Buying Activity

The following table shows recent insider purchases of Sagimet Biosciences Inc. (SGMT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 28, 2024	Happel David	President & CEO	Buy	12,100	$5.27	$63.7K	639,200
Dec 8, 2023	Happel David	President & CEO	Buy	1,600	$4.10	$6.6K	627,100
Nov 20, 2023	Happel David	President & CEO	Buy	590	$2.35	$1.4K	590
Jul 20, 2023	NEW ENTERPRISE ASSOCIATES 13 LP	10% Owner	Buy	30,000	$16.00	$480.0K	3,850,275
Jul 20, 2023	SEIDENBERG BETH C	Director	Buy	46,875	$16.00	$750.0K	46,875

SGMT Insider Selling Activity

The following table shows recent insider sales of Sagimet Biosciences Inc. (SGMT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 12, 2026	Chauche Thierry	officer: Chief Financial Officer	Sell	1,312	$5.36	$7.0K	15,688
Feb 12, 2026	Happel David	director, officer: President & CEO	Sell	12,101	$5.36	$64.9K	677,621
Feb 12, 2026	Martins Eduardo Bruno	officer: Chief Medical Officer	Sell	3,640	$5.36	$19.5K	103,296
Feb 12, 2026	Rozek Elizabeth	officer: Chief Legal & Admin. Officer	Sell	2,622	$5.36	$14.1K	190,959
Nov 21, 2025	Kemble George	Executive Chairman	Sell	37,688	$7.69	$290.0K	81,005-32%
Jul 23, 2025	Happel David	President & CEO	Sell	65,478	$9.13	$598.1K	689,722
Jul 23, 2025	Martins Eduardo Bruno	Chief Medical Officer	Sell	8,277	$9.13	$75.6K	106,936
Jul 23, 2025	Rozek Elizabeth	General Counsel and CCO	Sell	10,780	$9.13	$98.5K	183,726
Jul 25, 2024	Kemble George	Executive Chairman	Sell	23,625	$3.17	$74.8K	118,693
Jul 23, 2024	Kemble George	Executive Chairman	Sell	14,062	$3.10	$43.6K	142,318
Jul 23, 2024	Martins Eduardo Bruno	Chief Medical Officer	Sell	8,357	$3.10	$25.9K	81,213
Jul 23, 2024	Rozek Elizabeth	General Counsel and CCO	Sell	10,914	$3.10	$33.8K	160,506
Jul 20, 2023	NEW ENTERPRISE ASSOCIATES 13 LP	10% Owner	Sell	662	$16.00	$10.6K	3,820,275